Decades of renowned expertise and excellence
Atheris is a dynamic research-driven company
Atheris pursues a two-pronged development strategy:
1)Accelerate the development of its unique Lead Discovery Platform through internal efforts, academic and industrial collaborations.
2)Consolidate its technology platform and broaden the range of R&D Services offered to the Pharmaceutical, Biotechnology, Cosmetic and Food industries, also through contract research.
Using a proprietary library of bioactive peptides and proteins (see www.melusine.com), and in close collaboration with its partners, Atheris carries out R&D efforts across the discovery chain, spanning from the identification of drug candidates to the selection and optimisation of lead compounds. Atheris aims to contribute to the discovery of new drug candidates, bioactive ingredients and diagnostic markers, for the improvement of health care in a broad range of areas such as the Central Nervous, Cardiovascular, and Immune systems.